CSI Market
Sign In | Register

Maplight Therapeutics Inc (MPLT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MPLT quarterly Cash Flow →
Looking at cash flow data from Maplight Therapeutics Inc through provides insight into Dec 31 2025's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months
Operating Activities
Income-161.15
Depreciation & amortization0.58
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.01
Share-based Compensation36.01
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Common Stock Issued In Asset Purchase Agreement0.50
Noncash Lease Expense0.87
Increase Decrease In Operating Lease Liability-0.78
Increase Decrease In Deferred Grant Earnings-3.24
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable1.38
Increase (Decrease) in Accrued Liabilities2.90
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-13.10
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.10
Discontinued operations0.00
Net Cash flow from Operating Activities-138.14
Investing Activities
Capital Expenditures-0.47
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities85.50
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments-408.23
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-323.21
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-5.02
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.29
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock198.84
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Redeemable Convertible Preferred Stock And Preferred Stock Purchase Right Net Of Issuance Cost-
Proceeds From Initial Public Offering Of Common Stock And Private Placement Net Of Underwriting Fees275.72
Proceeds From Exercises Of Stock Options And Employee Stock Purchase Plan Issuances-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities469.82
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-138.61
Total Cash Flow8.48
4 historic quarters locked

Sign in to unlock the full Maplight Therapeutics Inc cash flow history.

Sign In Create Free Account

About Maplight Therapeutics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-125072

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License